AAAAAA
Results: 51-75/1113
Authors:
GREEN MD
KING CD
MOJARRABI B
MACKENZIE PI
TEPHLY TR
Citation: Md. Green et al., GLUCURONIDATION OF AMINES AND OTHER XENOBIOTICS CATALYZED BY EXPRESSED HUMAN UDP-GLUCURONOSYLTRANSFERASE 1A3, Drug metabolism and disposition, 26(6), 1998, pp. 507-512
Authors:
HARTMAN NR
LEO KU
BREWER TG
STRONG JM
Citation: Nr. Hartman et al., THE IN-VITRO METABOLISM OF PENCLOMEDINE IN MOUSE, RAT, AND HUMAN SYSTEMS, Drug metabolism and disposition, 26(6), 1998, pp. 513-519
Authors:
PRUEKSARITANONT T
DELUNA P
GORHAM LM
MA B
COHN D
PANG JM
XU X
LEUNG K
LIN JH
Citation: T. Prueksaritanont et al., IN-VITRO AND IN-VIVO EVALUATIONS OF INTESTINAL BARRIERS FOR THE ZWITTERION L-767,679 AND ITS CARBOXYL ESTER PRODRUG L-775,318 - ROLES OF EFFLUX AND METABOLISM, Drug metabolism and disposition, 26(6), 1998, pp. 520-527
Authors:
ANDERSSON SHG
LINDGREN A
POSTLIND H
Citation: Shg. Andersson et al., BIOTRANSFORMATION OF TOLTERODINE, A NEW MUSCARINIC RECEPTOR ANTAGONIST, IN MICE, RATS, AND DOGS, Drug metabolism and disposition, 26(6), 1998, pp. 528-535
Authors:
HAMELIN BA
BOUAYAD A
DROLET B
GRAVEL A
TURGEON J
Citation: Ba. Hamelin et al., IN-VITRO CHARACTERIZATION OF CYTOCHROME-P450 2D6 INHIBITION BY CLASSIC HISTAMINE H-1 RECEPTOR ANTAGONISTS, Drug metabolism and disposition, 26(6), 1998, pp. 536-539
Authors:
MUELLER SO
STOPPER H
DEKANT W
Citation: So. Mueller et al., BIOTRANSFORMATION OF THE ANTHRAQUINONES EMODIN AND CHRYSOPHANOL BY CYTOCHROME-P450 ENZYMES - BIOACTIVATION TO GENOTOXIC METABOLITES, Drug metabolism and disposition, 26(6), 1998, pp. 540-546
Authors:
KEARNEY MF
BRIEN JF
MARKS GS
LEI H
NAKATSU K
Citation: Mf. Kearney et al., THIOL AGENTS SEPARATE NITRIC-OXIDE FORMATION FROM VASODILATION INDUCED BY GLYCERYL TRINITRATE, Drug metabolism and disposition, 26(6), 1998, pp. 547-551
Authors:
KOUDRIAKOVA T
IATSIMIRSKAIA E
UTKIN I
GANGL E
VOUROS P
STOROZHUK E
ORZA D
MARININA J
GERBER N
Citation: T. Koudriakova et al., METABOLISM OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE INHIBITORS INDINAVIR AND RITONAVIR BY HUMAM INTESTINAL MICROSOMES AND EXPRESSED CYTOCHROME P4503A4 3A5 - MECHANISM-BASED INACTIVATION OF CYTOCHROME P4503A BY RITONAVIR/, Drug metabolism and disposition, 26(6), 1998, pp. 552-561
Authors:
WEISS M
Citation: M. Weiss, ANALYSIS OF METABOLITE FORMATION PHARMACOKINETICS AFTER INTRAVENOUS AND ORAL-ADMINISTRATION OF THE PARENT DRUG USING INVERSE LAPLACE TRANSFORMATION, Drug metabolism and disposition, 26(6), 1998, pp. 562-565
Authors:
HASHIZUME T
MISE M
TERAUCHI Y
O L
FUJII T
MIYAZAKI H
INABA T
Citation: T. Hashizume et al., N-DEALKYLATION AND HYDROXYLATION OF EBASTINE BY HUMAN LIVER CYTOCHROME-P450, Drug metabolism and disposition, 26(6), 1998, pp. 566-571
Authors:
ROTZINGER S
FANG J
BAKER GB
Citation: S. Rotzinger et al., TRAZODONE IS METABOLIZED TO M-CHLOROPHENYLPIPERAZINE BY CYP3A4 FROM HUMAN SOURCES, Drug metabolism and disposition, 26(6), 1998, pp. 572-575
Authors:
BUSCH U
SCHMID J
HEINZEL G
SCHMAUS H
BAIERL J
HUBER C
ROTH W
Citation: U. Busch et al., PHARMACOKINETICS OF MELOXICAM IN ANIMALS AND THE RELEVANCE TO HUMANS, Drug metabolism and disposition, 26(6), 1998, pp. 576-584
Authors:
ELMASRI HA
PORTIER CJ
Citation: Ha. Elmasri et Cj. Portier, PHYSIOLOGICALLY-BASED PHARMACOKINETICS MODEL OF PRIMIDONE AND ITS METABOLITES PHENOBARBITAL AND PHENYLETHYLMALONAMIDE IN HUMANS, RATS, AND MICE, Drug metabolism and disposition, 26(6), 1998, pp. 585-594
Authors:
NAKURA H
TATEISHI T
WATANABE M
ASOH M
TANAKA M
KUMAI T
KOBAYASHI S
Citation: H. Nakura et al., EFFECT OF HYPOALBUMINEMIA ON THE DISPOSITION OF THEOPHYLLINE - COMPARATIVE-STUDY WITH SPRAGUE-DAWLEY RATS AND A MUTANT SPRAGUE-DAWLEY HYPERLIPIDEMIC STRAIN WITH HYPOALBUMINEMIA, Drug metabolism and disposition, 26(6), 1998, pp. 595-597
Authors:
DUNN RT
KLAASSEN CD
Citation: Rt. Dunn et Cd. Klaassen, TISSUE-SPECIFIC EXPRESSION OF RAT SULFOTRANSFERASE MESSENGER-RNAS, Drug metabolism and disposition, 26(6), 1998, pp. 598-604
Authors:
SPRACKLIN DK
KHARASCH ED
Citation: Dk. Spracklin et Ed. Kharasch, HUMAN HALOTHANE REDUCTION IN-VITRO BY CYTOCHROME-P450 2A6 AND 3A4 - IDENTIFICATION OF LOW AND HIGH K-M ISOFORMS, Drug metabolism and disposition, 26(6), 1998, pp. 605-607
Authors:
STAINTEXIER F
SANDOUK P
SCHERRMANN JM
Citation: F. Staintexier et al., INTESTINAL-ABSORPTION AND STABILITY OF MORPHINE 6-GLUCURONIDE IN DIFFERENT PHYSIOLOGICAL COMPARTMENTS OF THE RAT, Drug metabolism and disposition, 26(5), 1998, pp. 383-387
Authors:
VICKERS S
DUNCAN CA
SLAUGHTER DE
ARISON BH
GREBER T
OLAH TV
VYAS KP
Citation: S. Vickers et al., METABOLISM OF MK-499, A CLASS-III ANTIARRHYTHMIC AGENT, IN RATS AND DOGS, Drug metabolism and disposition, 26(5), 1998, pp. 388-395
Authors:
LEE CH
WATT KC
CHANG AM
PLOPPER CG
BUCKPITT AR
PINKERTON KE
Citation: Ch. Lee et al., SITE-SELECTIVE DIFFERENCES IN CYTOCHROME-P450 ISOFORM ACTIVITIES - COMPARISON OF EXPRESSION IN RAT AND RHESUS-MONKEY LUNG AND INDUCTION IN RATS, Drug metabolism and disposition, 26(5), 1998, pp. 396-400
Authors:
LEE MG
CHIOU WL
Citation: Mg. Lee et Wl. Chiou, MECHANISM OF ASCORBIC-ACID ENHANCEMENT OF THE BIOAVAILABILITY AND DIURETIC EFFECT OF FUROSEMIDE, Drug metabolism and disposition, 26(5), 1998, pp. 401-407
Authors:
CHANDO TJ
EVERETT DW
KAHLE AD
STARRETT AM
VACHHARAJANI N
SHYU WC
KRIPALANI KJ
BARBHAIYA RH
Citation: Tj. Chando et al., BIOTRANSFORMATION OF IRBESARTAN IN MAN, Drug metabolism and disposition, 26(5), 1998, pp. 408-417
Authors:
JOQUEVIEL C
MARTINO R
GILARD V
MALETMARTINO M
CANAL P
NIEMEYER U
Citation: C. Joqueviel et al., URINARY-EXCRETION OF CYCLOPHOSPHAMIDE IN HUMANS, DETERMINED BY P-31 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY, Drug metabolism and disposition, 26(5), 1998, pp. 418-428
Authors:
SAUER JM
SMITH RL
BAO JQ
KATTNIG MJ
KUESTER RK
SIPES IG
Citation: Jm. Sauer et al., METABOLIC AND DISPOSITIONAL FATE OF 1,2-DIBROMO-2,4-DICYANOBUTANE IN THE MALE FISCHER-344 RAT, Drug metabolism and disposition, 26(5), 1998, pp. 429-436
Authors:
WORMHOUDT LW
HISSINK AM
COMMANDEUR JNM
VANBLADEREN PJ
VERMEULEN NPE
Citation: Lw. Wormhoudt et al., DISPOSITION OF 1,2-[C-14]DIBROMOETHANE IN MALE WISTAR RATS, Drug metabolism and disposition, 26(5), 1998, pp. 437-447
Authors:
PRAKASH C
CUI DH
BAXTER JG
BRIGHT GM
MICELI J
WILNER K
Citation: C. Prakash et al., METABOLISM AND EXCRETION OF A NEW ANXIOLYTIC DRUG CANDIDATE, CP-93,393, IN HEALTHY MALE-VOLUNTEERS, Drug metabolism and disposition, 26(5), 1998, pp. 448-456